HomeMarket NewsThe Tale of Triumph: Cibus Surpasses Earnings Per Share and Revenue Expectations...

The Tale of Triumph: Cibus Surpasses Earnings Per Share and Revenue Expectations in Q4 2023

By Ron Finklestien
Current Market Analysis

Actionable Trade Ideas

always free

CBUS stock - CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023

Source: iQoncept / Shutterstock

Cibus (NASDAQ:CBUS) has unveiled its performance for the final quarter of 2023.

  • Recorded earnings per share stood at $1.87, surpassing the expected EPS of -$1.43 projected by analysts.
  • The company achieved revenue of $1.10 million, significantly exceeding the forecasted revenue of $380,000 by a staggering 190.26%.

Delving into the realm of earnings reports, InvestorPlace Earnings unearths critical data from TradeSmith to automatically analyze quarterly earnings. With a keen eye on metrics like earnings per share and revenue, we unravel how a corporation measures up against analyst predictions. Our objective? Speedily disseminating the latest financial figures for our discerning readers. Questions? Doubts? Reach out to us at editor@investorplace.com.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/cbus-stock-earnings-cibus-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.

Read Now

Related Articles

spot_img

WallStreet Waves

Comprehensive stock market news coverage across various asset classes, including stocks, bonds, commodities, cryptocurrencies, and more. We believe in offering a holistic perspective, allowing our readers to stay ahead of the stock market and capitalize on emerging opportunities in tech stocks, small caps, biotechs and more!

most Popular

trending right now

© 2024 All Rights reserved | Powered by WallStreet Waves